Nurse Practitioner, Family · Westford, MA
NPI
1184972507
Since 2012
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
174 Littleton Rd, Minuteclinic
Westford, MA, 01886
Phone (978) 692-2111
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
1,004 services
Medicare patients, 2024
271
Average age 69
Drug cost, 2024
$3.0M
6,103 prescriptions
Company payments, 2025
$488
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kerry Watroba was code 99214 (office e&m - established), 473 times for 251 patients. In total Kerry Watroba billed 1,004 services in 12 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 473 | 251 | $81.61 | $39K |
| 95251 Test - Miscellaneous | Office | 182 | 115 | $23.98 | $4,364 |
| 82962 Clinical Chemistry | Office | 131 | 112 | $3.21 | $421 |
| 83036 Blood Count | Office | 97 | 87 | $9.32 | $904 |
| 82947 Clinical Chemistry | Office | 59 | 59 | $3.72 | $219 |
| 99204 Office E&M - New | Office | 27 | 27 | $108.75 | $2,936 |
| 99213 Office E&M - Established | Office | 14 | 13 | $64.43 | $902 |
| 95250 Test - Miscellaneous | Office | 12 | 11 | $128.98 | $1,548 |
By year: 2022 $48K for 999 services; 2023 $52K for 1,247 services; 2024 $50K for 1,004 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 131 | 112 | $3.21 | $421 |
| 83036 Blood Count | 97 | 87 | $9.32 | $904 |
| 82947 Clinical Chemistry | 59 | 59 | $3.72 | $219 |
Medicare prescription drug claims, 2024
In 2024, the drug Kerry Watroba prescribed most often to Medicare patients was Metformin Hcl, with 423 prescriptions and refills. In total Kerry Watroba wrote 6,103 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 423 | 1,017 | 118 | $4,235 |
| Ozempic Semaglutide | 403 | 618 | 88 | $580K |
| Metformin Hcl Er Metformin Hcl | 366 | 838 | 100 | $6,116 |
| Jardiance Empagliflozin | 363 | 712 | 90 | $404K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 312 | 728 | 123 | $34K |
| Trulicity Dulaglutide | 301 | 396 | 73 | $379K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 268 | 576 | 79 | $37K |
| Atorvastatin Calcium Generic | 215 | 544 | 67 | $3,032 |
| Mounjaro Tirzepatide | 210 | 230 | 40 | $229K |
| Tresiba Flextouch U-200 Insulin Degludec | 162 | 336 | 44 | $205K |
| Tresiba Flextouch U-100 Insulin Degludec | 128 | 266 | 40 | $76K |
| Humalog Kwikpen U-100 Insulin Lispro | 121 | 228 | 40 | $33K |
| Levothyroxine Sodium Generic | 113 | 253 | 33 | $1,297 |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 111 | 200 | 30 | $30K |
| Rosuvastatin Calcium Generic | 106 | 251 | 28 | $2,342 |
Brand drugs: 3,306 claims; generic drugs: 1,903 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kerry Watroba $488 ($488 in general payments such as food, travel and fees) from 12 companies. The largest payer was CeQur Corporation with $152.
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $152 |
| Novo Nordisk Inc NVO | 2 | $45.13 |
| Lilly USA, LLC LLY | 2 | $42.35 |
| Medtronic, Inc. MDT | 2 | $41.42 |
| Insulet Corporation PODD | 1 | $33.95 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $30.21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.79 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $25.68 |
| Amgen Inc. AMGN | 1 | $25.48 |
| Madrigal Pharmaceuticals MDGL | 1 | $25.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.